Combined effects of benidipine and diltiazem in a rat model of experimental angina

Journal of Pharmacological Sciences

Volumn 95, Issue 3, 2004, Pages 394-397

  Yao, Kozo ^a   Shirakura, Shiro ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Angina; Benidipine; Diltiazem

Indexed keywords

BENIDIPINE; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; VASOPRESSIN;

ADOLESCENT; ANGINA PECTORIS; ANIMAL MODEL; ANTIANGINAL EFFECT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; EXPERIMENTAL ANGINA PECTORIS; EXPERIMENTAL MODEL; HEART MUSCLE ISCHEMIA; HEART RATE; LOW DRUG DOSE; MALE; NONHUMAN; QRS COMPLEX; RAT; S WAVE; S WAVE DEPRESSION;

EID: 3843074261     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.SC0030119     Document Type: Article

References (15)

1. 2+ channel blocker with a cardio-protective effect. Cardiovasc Drug Rev. 1999;17:1-15.
2. Karasawa A, Kubo K, Shuto K, Oka T, Nakamizo N. Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study. Arzneimittelforschung. 1988; 38:1702-1707.
3. Klein WW, Jackson G, Tavazzi L. Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis. Coron Artery Dis. 2002;13:427-436.
4. Temkin LP. High-dose monotherapy and combination therapy with calcium channel blockers for angina. A comprehensive review of the literature. Am J Med. 1989;86:23-27.
5. Frishman W, Charlap S, Kimmel B, et al. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment. Circulation. 1988;77:774-786.
6. Toyosaki N, Toyo-oka T, Natsume T, et al. Combination therapy with diltiazem and nifedipine in patients with effort angina pectoris. Circulation. 1988;77:1370-1375.
7. Hirata Y, Miyai H, Mabuchi Y, Aisaka K. Effect of JTV-506, a novel vasodilator, on experimental angina model in rats. J Cardiovasc Pharmacol. 1998;31:322-326.
8. Maturi MF, Martin SE, Markle D, et al. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Circulation. 1991;83:2111-2121.
9. Satoh S, Ikegaki I, Toshima Y, Watanabe A, Asano T, Shimokawa H. Effects of Rho-kinase inhibitor on vasopressin-induced chronic myocardial damage in rats. Life Sci. 2002; 72:103-112.
10. + exchange inhibitor, on myocardial ischemia and experimental angina models in rats. Jpn J Pharmacol. 2000;84:196-205.
11. Mori T, Ishigai Y, Fukuzawa A, Chiba K, Shibano T. Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model. Br J Pharmacol. 1995;116:1668-1672.
12. Rothman MT, Khan B. Coronary artery spasm. Br J Clin Prac. 1991;45:129-134.
13. Moriyama T, Karasawa A. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Biol Pharm Bull. 1994;17:1468-1471.
14. Quartaroli M, Gambini F, Tarter G, Micheli D, Trist DG, Gaviraghi G. The hemodynamic effects of lacidipine in anesthetized dogs: comparison with nitrendipine, amlodipine, verapamil, and diltiazem. J Cardiovasc Pharmacol. 1991;18: 326-336.
15. Haines DE, DiMarco JP. Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up. J Am Coll Cardiol. 1990;15:1345-1354.